Samoa's Electoral Court has unseated Deputy Prime Minister Toelupe Poumulinuku Onesemo after finding he was connected to a ...

Samoa Joe has been away from AEW television due to an injury that he sustained whilst training. Early last month, there was no indication whether he'd be back any time soon per reports at the time, ...

ProMIS Neurosciences, Inc. discovers and develops antibody therapies and therapeutic vaccines for neurodegenerative diseases and other misfolded protein diseases in Canada. The company’s proprietary ...

Across his career, Samoa Joe has come face-to-face in the ring with many of the industry's biggest titans, both in name and stature. Among all of his opponents, however, Joe is able to identify one ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

The Prime Ministers of Samoa and New Zealand hold a press conference after a Cabinet meeting in Apia. Photo / Julia Gabel Samoa’s Prime Minister has told Christopher Luxon to ignore the social media ...

Remote, rarely visited, and unlike any other park in the national system, this South Pacific park offers pristine beaches, unique cultural immersion, and world-class coral reefs. Travelers visiting ...

Christopher Luxon Speaks to the media from Samoa Video / RNZ New Zealand and Samoa have signed arrangements between their police and customs departments to bolster action against what Prime Minister ...

©2021, EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

(Bloomberg) — Giorgia Meloni has long pitched nuclear energy as a cure for Italy’s wilting economy. Now her government is plotting how to actually resurrect the banned technology. Almost 40 years ...

A study of Roche's Gazyva has raised the prospect of a first approved therapy for primary membranous nephropathy (pMN), a rare autoimmune kidney disorder. The phase 3 MAJESTY trial of anti-CD20 ...